Company
Prometheus Biosciences, Inc. (0001718852)
Standardized SEC financial data for Prometheus Biosciences, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001718852 · Pharmaceutical Preparations.
Operating margin
-1000.0%
Net margin
-1000.0%
Revenue growth (YoY)
117.6%
Return on equity
-21.0%
ROIC
-29.5%
Free cash flow
-$126.0M
Debt / equity
0.01×
Current ratio
31.04×
Ratios for fiscal year 2022, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Revenue | $1.2M | $3.1M | $6.8M |
| R&D expense | $19.1M | $62.4M | $112.8M |
| SG&A expense | $11.1M | $28.5M |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Cash & equivalents | $4.5M | $54.2M | $257.3M | $292.4M |
| Total current assets | — | $57.5M | $265.4M | $708.2M |
Cash flow
| USD | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Operating cash flow | -$29.9M | -$63.5M | -$123.3M |
| Capital expenditures | $204K | $1.1M | $2.7M |
| Free cash flow | -$30.1M | -$64.6M |
Get 0001718852 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001718852/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001718852/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"